Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Autoimmune Disease
Data on autoimmune disease described by H.A. Ferreyra et al
June 2nd, 2009
In this recently published article, scientists in the United States conducted a study "To report the results of treating autoimmune retinopathy (AIR) with immunosuppression therapy. Retrospective review of 30 consecutive patients with AIR followed for 3 to 89 months (median, 17 months) who were treated with immunosuppression (systemic or local)." "Subgroups were cancer-associated retinopathy (CAR), nonparaneoplastic AIR (npAIR), and npAIR with cystoid macular edema (npAIR/CME). Outcome measures were improvement of Snellen visual acuity by at least 2 lines, expansion of the visual field area by more than 25%, and resolution of CME. Overall, 21 of 30 patients (70%)...
Source: Cancer Weekly (2009-06-02)
|
